HIV and AIDS in 2030: A Choice Between Two Futures

Voices from Two Futures

Leaders of the AIDS response in 2030 discuss what we are doing in 2020

What Will They Say About Us?

What will future leaders of the global AIDS response say about what we are doing right now? In the months leading up to the 2020 AIDS Conference, we will be providing regular commentary from a panel of experts in 2030 addressing actions and issues in 2020.

2030 will mark the first half century of the HIV and AIDS epidemic. Future leaders will take the opportunity to look back and assess the global response, identifying what was done well and what was done badly. What will they say about what we are doing right now? That will depend largely on what kind of future we give to them. If we achieve epidemic control by 2030, future leaders will be grateful and full of praise for our perseverance. But if there is a resurgence of HIV and AIDS in the 2020s, future leaders will judge us harshly for failing to do what could have been done.


Recent reports


The Two Futures

Slide77.jpeg

In the losing future, HIV and AIDS make a resurgence in the 2020s. By 2030, the rate of AIDS-related deaths has risen to 1.45 million annually, and the rate of new HIV infections has risen to 1.90 million. Of the 44 million people living with HIV, only 54% have achieved viral suppression.

Slide76.jpeg

In the winning future, the progress against HIV and AIDS continues through the 2020s with epidemic control achieved by 2030. By 2030, the rate of AIDS-related deaths has declined to 340,000 annually, and the rate of new HIV infections has declined to 260,000. Of the 42 million people living with HIV, only 89% have achieved viral suppression..tee viral suppression.


Expert Panelists in 2030

The same leaders of the global AIDS response in 2030 serve on the panels in both futures. Their backgrounds and experience are the same with two exceptions: in the winning future, two panelists left their positions when their organizations were closed down because they were no longer needed.

Dr Bennett.jpg

Olivia Bennett, PhD

President and Chief Executive Officer

Campaign to End AIDS in America

Dr. Bennett is from the United States. She is the President and Chief Executive Officer of the Campaign to End AIDS in America, a leading AIDS advocacy organization in the United States. Dr. Bennett earned her PhD in Public Policy from the University of Chicago. In 2024, she was named to lead the Campaign to End AIDS in America. [Note: in the winning future, the Campaign to End AIDS in America was closed down in 2028, following the success of the United States’ Ending the HIV Epidemic program. Dr Bennet joined the faculty of Yale University in the School of Public Health shortly thereafter.]

Voice by Teresa Welch

De+Jong.jpg

Joost De Jong

Executive Director

Worldwide HIV Network

Mr. De Jong is from the Netherlands. He is the Executive Director of WHN, the Worldwide HIV Network. For many years, Mr. De Jong has been a prominent advocate for the human rights of people living with HIV or at risk of HIV infection. He was named the Executive Director of WHN in 2025.

Voice by Christo Greyling

Imam+Karume.jpg

Ahmed Karume, BA

Executive Director

INERELA+

Imam Karume is from Kenya. He is the Executive Director of INERELA+, the International Network of Religious Leaders Living with or Personally Affected by HIV or AIDS. Imam Karume received his undergraduate degree at Umma University in Kenya and his religious training at the London Muslim Centre. He served numerous congregations in Kenya and then joined the staff of INERELA+ in 2023. He became Executive Director in 2028.

Voice by Moses Kamoga

Rev+Morgan.jpg

Emily Morgan, MTh, DD

Executive Director

Christian Health Alliance

Rev. Morgan is from the United States. She is the Executive Director of Christian Health Alliance, an umbrella organization for a number of Christian NGOs. Rev. Morgan is an ordained pastor. She was educated at the Boston University School of Theology. She served as a health missionary in a variety of countries before joining CHA in 2021. She has been the Executive Director of CHA since 2028.

Voice by Kathy Erb

Dr+Nkosi.jpg

Munashe Nkosi, MD

Executive Director

The Global Fund to Fight AIDS, Tuberculosis and Malaria

Dr. Nkosi is from South Africa. She is the Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. She received her medical degree from the University of Cape Town, specializing in Infectious Diseases. She joined WHO in 2006, serving in various positions before moving over to the Global Fund to become Executive Director in 2027.

Voice by Neo Mohapi

Dr+Okafor.jpg

Chibuzo Okafor, PhD

Director of African Projects

International Interfaith Relief Services

Dr. Okafor is from Nigeria. He is the Director of African Projects for International Interfaith Relief Services. He earned his undergraduate degree in Health Sciences at the University of Lagos and a PhD in Public Health from the University of Nigeria. He has served with IIRS for more than twenty years at many locations around the world. He was named Director of Africa Projects in 2027 and is based in Lagos.

Voice by Meman Mwandila

Amb+Rogers.jpg

Christopher Rogers, MD, PhD

United States Global AIDS Coordinator

PEPFAR

Amb. Rogers is from the United States. He is the Global AIDS Coordinator and the director of the PEPFAR program. He earned his PhD in International Development from Stanford University. He worked for many years at USAID before returning to Harvard Medical School, where he earned an MD with a specialty in Epidemiology. He joined PEPFAR in 2016 and was selected to lead the agency in 2023. [Note: in the winning future, PEPFAR was ended in 2028 since it was no longer needed. Amp. Rogers retired from public service after his time at PEPFAR.]

Voice by Ambassador Jimmy Kolker

Dr+Thomas.jpg

Jaylen Thomas, MD, PhD

Director

United States Centers for Disease Control and Prevention

Dr. Thomas is from the United States. He is the Director of the Centers for Disease Control and Prevention in the United States. He earned an MD in Primary Care from Columbia University and then a PhD in Public Health from Johns Hopkins University. He served for many years at UNAIDS and WHO before being named the Director of the CDC in 2022.

Voice by Ulysses Burley

Dr+Zhjang.jpg

Zhang Xiu Ying, PhD

Director-General

World Health Organization

Dr. Zhang is from China. She is the Director-General of the World Health Organization. She earned her undergraduate degree at Tsinghua University and her PhD from the University of Oxford, with a specialization in International Health Policy. During her twenty-year career, she has worked for numerous international health organizations. She was selected to lead the Global Fund to Fight AIDS, Tuberculosis and Malaria in 2026.

Voice by Huang Hong